Mounjaro® fra Eli Lilly godkendt af FDA. Hvad nu?
-
FDA godkendte Mounjaro
fra Eli Lilly i forrige uge. Jeg har samlet nogle figurer og tabeller i et indlaeg paa min blog, som jeg synes viser, at Novo Nordisk de naeste par aar stadig staar staerkest baade hvad angaar sukkersyge og fedme.What happens next following FDA approval of Mounjaro
from Eli Lilly for diabetes?
https://blog.midgardfinance.com/2022/05/22/what-happens-next-following-fda-approval-of-mounjaro-from-eli-lilly-for-diabetes/Disclaimer: Jeg har aktier i Novo Nordisk.
-
Hov, der sneg sig en fejl ind i tabellen. Trulicity er ugentlig indsproejtning og ikke daglig.
-
Jeg var lige forbi Pfizers pipeline. De har GLP1R-agonisten Ponsegromab i fase 1 og Ervogastat+ Clesacostat i fase 2. De arbejder ogsaa paa NASH ligesom Novo, Lilly, Boehringer Ingelheim og andre. Boehringer har ogsaa en GLP1R/GCGR-agonist til behandling af fedme i fase 2. Jeg tror virkelig Wegovy
bliver en guldkalv. -
Her er et par figurer, som jeg ikke inkluderede i blog-indlaegget. Klik paa figurerne for at goere dem stoerre.
-
The Doctor Prescribed an Obesity Drug. Her Insurer Called It 'Vanity.' https://nyti.ms/3azxovx
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind